Cargando…

An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes

BACKGROUND: Microarray technology may offer a new opportunity to gain insight into disease-specific global protein expression profiles. The present study was performed to apply a serum antibody microarray to screen for differentially regulated cytokines in Parkinson's disease (PD), multiple sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahlknecht, Philipp, Stemberger, Sylvia, Sprenger, Fabienne, Rainer, Johannes, Hametner, Eva, Kirchmair, Rudolf, Grabmer, Christoph, Scherfler, Christoph, Wenning, Gregor K, Seppi, Klaus, Poewe, Werner, Reindl, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539904/ https://www.ncbi.nlm.nih.gov/pubmed/23173604 http://dx.doi.org/10.1186/1477-5956-10-71

Ejemplares similares

Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
por: Grossauer, Anna, et al.
Publicado: (2023)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
por: Krismer, Florian, et al.
Publicado: (2020)

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis
por: Krismer, Florian, et al.
Publicado: (2019)

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
por: Bajaj, Sweta, et al.
Publicado: (2017)

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

Prevalence and Burden of Gait Disorders in Elderly Men and Women Aged 60–97 Years: A Population-Based Study
por: Mahlknecht, Philipp, et al.
Publicado: (2013)

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye‐Tracking Study
por: Carbone, Federico, et al.
Publicado: (2021)

Prodromal Parkinson's disease: hype or hope for disease-modification trials?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)
por: Esterhammer, Regina, et al.
Publicado: (2015)

Automated segmentation of deep brain nuclei using convolutional neural networks and susceptibility weighted imaging
por: Beliveau, Vincent, et al.
Publicado: (2021)

Genetic players in multiple system atrophy: unfolding the nature of the beast
por: Stemberger, Sylvia, et al.
Publicado: (2011)

Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study
por: Mahlknecht, Philipp, et al.
Publicado: (2020)

Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
por: Leys, Fabian, et al.
Publicado: (2022)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes
por: Schröter, Nils, et al.
Publicado: (2022)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
por: Kuzdas, Daniela, et al.
Publicado: (2013)

Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
por: Fellner, Lisa, et al.
Publicado: (2013)

Symptomatic hemiparkinsonism due to extensive middle and posterior fossa arachnoid cyst: case report
por: Wimmer, Bernadette, et al.
Publicado: (2020)

No effect of age, gender and total intracranial volume on brainstem MR planimetric measurements
por: Mangesius, Stephanie, et al.
Publicado: (2020)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
por: Krismer, Florian, et al.
Publicado: (2022)

Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
por: Starhof, C., et al.
Publicado: (2018)

Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)

Cognition in multiple system atrophy: a single‐center cohort study
por: Eschlböck, Sabine, et al.
Publicado: (2020)

Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder
por: Sprenger, Fabienne S., et al.
Publicado: (2015)

Disability Milestones and Death in Parkinson's Disease under Subthalamic Neurostimulation
por: Mahlknecht, Philipp, et al.
Publicado: (2023)

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
por: Kühnel, Line, et al.
Publicado: (2022)

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
por: van Eimeren, Thilo, et al.
Publicado: (2019)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rdkatepfqvojim2bvfrmgq99er